Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd R Harris

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|April 4, 2018
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory PainRené Blöcher, Karen M Wagner, Raghavender R Gopireddy, et al.
Journal of Cardiovascular Pharmacology|May 17, 2013
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertensionArzu Ulu, Todd R Harris, Christophe Morisseau, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 7, 2012
Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic ratsKathleen Guglielmino, Kaleena Jackson, Todd R Harris, et al.
Environmental Science. Advances|May 14, 2023
Distinct profiles of oxylipid mediators in liver, lung, and placenta after maternal nano-TiO<sub>2</sub> nanoparticle inhalation exposureTodd R Harris, Julie A Griffith, Colleen E C Clarke, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|April 4, 2018
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory PainRené Blöcher, Karen M Wagner, Raghavender R Gopireddy, et al.
Journal of Cardiovascular Pharmacology|May 17, 2013
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertensionArzu Ulu, Todd R Harris, Christophe Morisseau, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 7, 2012
Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic ratsKathleen Guglielmino, Kaleena Jackson, Todd R Harris, et al.
Environmental Science. Advances|May 14, 2023
Distinct profiles of oxylipid mediators in liver, lung, and placenta after maternal nano-TiO<sub>2</sub> nanoparticle inhalation exposureTodd R Harris, Julie A Griffith, Colleen E C Clarke, et al.
Pageof 3